R3 Stem Cell Transplant Found to Reduce MS Relapses
A new meta-analysis found that autologous hematopoietic stem cell transplant (aHSCT), which tries to “reset” the immune system, generally lowers disability and recurrence rates in persons with multiple sclerosis (MS). What is an autologous hematopoietic Stem Cell Transplant? While the operation has been used for years to treat some cancers, its use in MS has […]